Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 13, 2013
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA
Deal Size : Inapplicable
Deal Type : Inapplicable
Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 21, 2012
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 23, 2011
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 18, 2011
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 13, 2010
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 22, 2010
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
